Paper17575235
[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma.
Wicki A and 10 others. Clin Cancer Res, 2007. Cited by 78 papers, by iCite.
Cite this record
ConductScience Library. [Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma. Papers, record 17575235. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17575235
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- [Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Indium Radioisotopes | Major topic |
| Insulinoma | Major topic |
| Organometallic Compounds | Major topic |
| Pancreatic Neoplasms | Major topic |
| Peptides | Major topic |
| Radiopharmaceuticals | Major topic |
| Receptors, Glucagon | Major topic |
| Animals | |
| Cell Proliferation | |
| Female | |
| Glucagon-Like Peptide-1 Receptor | |
| Male | |
| Mice | |
| Mice, Transgenic | |
| Pentetic Acid | |
| Radionuclide Imaging | |
| Tissue Distribution |
Source PubMed
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41088364 | Engineered GLP-1R-targeting nanoplatforms: multimodal therapeutics in human diseases. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/41088364 | PubMed |
| 39911322 | Unlocking the multifaceted roles of GLP-1: Physiological functions and therapeutic potential. | Toxicol Rep | 2025 | https://conductscience.org/library/papers/39911322 | PubMed |
| 37780209 | Theranostic in GLP-1R molecular imaging: challenges and emerging opportunities. | Front Mol Biosci | 2023 | https://conductscience.org/library/papers/37780209 | PubMed |
| 37242457 | Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37242457 | PubMed |
| 37109517 | Role of Exendin-4 Functional Imaging in Diagnosis of Insulinoma: A Systematic Review. | Life (Basel) | 2023 | https://conductscience.org/library/papers/37109517 | PubMed |
| 36569936 | GLP-1 receptor agonist as a modulator of innate immunity. | Front Immunol | 2022 | https://conductscience.org/library/papers/36569936 | PubMed |
| 33019671 | Beta Cell Imaging-From Pre-Clinical Validation to First in Man Testing. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33019671 | PubMed |
| 31903131 | Advances in GLP-1 receptor targeting radiolabeled agent development and prospective of theranostics. | Theranostics | 2020 | https://conductscience.org/library/papers/31903131 | PubMed |
| 31378283 | Molecular imaging of β-cells: diabetes and beyond. | Adv Drug Deliv Rev | 2019 | https://conductscience.org/library/papers/31378283 | PubMed |
| 31070270 | Exendin-4 analogs in insulinoma theranostics. | J Labelled Comp Radiopharm | 2019 | https://conductscience.org/library/papers/31070270 | PubMed |
| 28295000 | Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms. | Pharmaceuticals (Basel) | 2017 | https://conductscience.org/library/papers/28295000 | PubMed |
| 28025655 | Targets and probes for non-invasive imaging of β-cells. | Eur J Nucl Med Mol Imaging | 2017 | https://conductscience.org/library/papers/28025655 | PubMed |
| 27826137 | Imaging in pancreatic disease. | Nat Rev Gastroenterol Hepatol | 2017 | https://conductscience.org/library/papers/27826137 | PubMed |
| 27630114 | Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes. | Pharmacol Rev | 2016 | https://conductscience.org/library/papers/27630114 | PubMed |
| 27327034 | A Helix-Stabilizing Linker Improves Subcutaneous Bioavailability of a Helical Peptide Independent of Linker Lipophilicity. | Bioconjug Chem | 2016 | https://conductscience.org/library/papers/27327034 | PubMed |
| 26993859 | Effects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes. | Br J Pharmacol | 2016 | https://conductscience.org/library/papers/26993859 | PubMed |
| 26909131 | Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals. | World J Gastrointest Oncol | 2016 | https://conductscience.org/library/papers/26909131 | PubMed |
| 26194012 | Quantitative Impact of Plasma Clearance and Down-regulation on GLP-1 Receptor Molecular Imaging. | Mol Imaging Biol | 2016 | https://conductscience.org/library/papers/26194012 | PubMed |
| 26069859 | Dosimetry of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 in rodents, pigs, non-human primates and human - repeated scanning in human is possible. | Am J Nucl Med Mol Imaging | 2015 | https://conductscience.org/library/papers/26069859 | PubMed |
| 25973333 | Dosimetry of [(177)Lu]-DO3A-VS-Cys(40)-Exendin-4 - impact on the feasibility of insulinoma internal radiotherapy. | Am J Nucl Med Mol Imaging | 2015 | https://conductscience.org/library/papers/25973333 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GLP1R | 2740 | PubTator's text mining | https://conductscience.org/library/genes/2740 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17575235
GET https://conductscience.org/api/papers/v1/17575235/cited_by?page=2